Shares of Mirum Pharmaceuticals, Inc. (MIRM) were in the spotlight on Monday after the company announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of its ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

Data from patients across 3 different randomized controlled trials showed improvements in both adiponectin and PRO-C3, primary end points in the trials.

Modern dietary habits have made liver disease increasingly common, but the condition remains notoriously difficult to detect.

The announcement adds to a string of setbacks in Pfizer’s bid to win a slice of the booming market that Wall Street projects ...

The increase in alcohol deaths in England since the pandemic in 2020 is an ‘acute crisis’ and requires urgent intervention ...

The higher rate of alcohol deaths in England since the start of the Covid pandemic represents an ‘acute crisis’, according to ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...